THIRUVANANTHAPURAM: The Association of Medical and Paediatric Oncologists of Kerala (AMPOK) announced a research grant of Rs ...

Harry Monroe has been an educator for 51 years. He spent 33 of those with Dallas ISD. Now, he's leaving for health reasons.

Diversified Trust Co decreased its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 40.3% during the ...

New research shows that low-intensity repetitive transcranial magnetic stimulation (rTMS) can restore key synaptic structures in mouse models of Alzheimer’s disease.

Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people ...

Scientists in Australia have discovered that a magnetic brain treatment already used for depression can boost the brain’s ...

BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its target price hoisted by Wells Fargo & Company from $67.00 to $76.00 in a ...

Detailed price information for Bridgebio Pharma Inc (BBIO-Q) from The Globe and Mail including charting and trades.

Cardiac amyloidosis portends a poor prognosis, with a median survival less than 6 months without treatment. However, if it is recognized early, there are specific treatments available.

Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people worldwide. Synapses are ...

AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months.